Soleus Capital Management’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Soleus Capital Management's PRAX Position: Q3 2026 in Review
Soleus Capital Management reduced its Praxis Precision Medicines (PRAX) stake by 68% in Q3 2026, selling an estimated $40M and leaving 56,515 shares worth $16.5M. The position accounts for 0.59% of the portfolio, ranked #39.
Soleus Capital Management first reported a position in PRAX in Q2 2023 and has held it in 13 quarters since. The position peaked at $107M in Q4 2025. 337 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Soleus Capital Management held 56,515 shares of Praxis Precision Medicines worth $16.5M as of Q3 2026.
- Soleus Capital Management sold 121,002 Praxis Precision Medicines shares in Q3 2026, an estimated $40M.
- Praxis Precision Medicines made up 0.59% of Soleus Capital Management's portfolio in Q3 2026, its #39 holding.
- Soleus Capital Management first reported a position in Praxis Precision Medicines in Q2 2023 and has held it in 13 quarters since.
- Soleus Capital Management's Praxis Precision Medicines position peaked at $107M in Q4 2025.
- 337 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.